Advertisement

Topics

STAT Plus: FDA slammed for ‘reckless decision’ to allow a gout drug to remain available, despite heart risks

13:38 EST 22 Feb 2019 | STAT

In a Solomon-like move, the FDA allowed the gout drug to stay on the market but will require a Black Box warning about heart risks.

Original Article: STAT Plus: FDA slammed for ‘reckless decision’ to allow a gout drug to remain available, despite heart risks

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: FDA slammed for ‘reckless decision’ to allow a gout drug to remain available, despite heart risks"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...